5 results
inhibitors dosing dpp4 sglt2 agonists glp1 management medications renal
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Summary Mechanisms ... amputation and bone ... #Summary #DM2 # ... diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... Major Advantages: None ... #Summary #DM2 # ... diabetes #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... the first one ( ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... to DPP4s from one ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
One unique thing ... different than other medications ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
No results found for "pathophysiology pharmacology diabetes antibiotics idsa bone dm2 summary indications endocrinology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #pathophysiology #pharmacology #diabetes #antibiotics #idsa #bone #dm2 #summary #indications #endocrinology